You are here

Article metrics

Article menu
Immunotherapy biomarkers
Original research
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

 

Online download statistics by month:

Online download statistics by month: March 2021 to September 2025

AbstractFullPdf
Mar 2021800799232
Apr 202124524599
May 202122322383
Jun 202120320363
Jul 202114014065
Aug 202117517553
Sep 202114914972
Oct 202114714775
Nov 202114414567
Dec 202113414155
Jan 202211111648
Feb 2022828442
Mar 202215917470
Apr 202214515464
May 202215516573
Jun 202211611741
Jul 202210811242
Aug 202212513739
Sep 20229910134
Oct 202212012240
Nov 202210210654
Dec 2022999935
Jan 2023909128
Feb 202313213324
Mar 202314514645
Apr 2023939333
May 2023929347
Jun 2023888844
Jul 2023909536
Aug 202310711022
Sep 2023979923
Oct 20239710137
Nov 202311611734
Dec 202311811928
Jan 2024909334
Feb 202411111237
Mar 202412713152
Apr 202414114253
May 202411611740
Jun 2024939337
Jul 202430530659
Aug 202414214041
Sep 202418118242
Oct 202421922051
Nov 202423023359
Dec 202417918131
Jan 202515015039
Feb 202518218244
Mar 202518818836
Apr 202523023151
May 202516316443
Jun 202511211333
Jul 2025110
Sep 2025110
Total800781192629